透析相关淀粉样变模拟转移性骨病:骨SPECT/CT上非MDP高摄取溶骨性病变的闪烁显像陷阱
本文报道一例70岁长期透析女性,因股骨颈病理性骨折及邻近溶骨性病变就诊,初期怀疑转移瘤或棕色瘤。骨SPECT/CT显示仅骨折部位有摄取,溶骨性病变呈背景活性,组织病理学经刚果红染色确诊淀粉样变。提示透析相关淀粉样变可表现为骨显像上非MDP高摄取的溶骨性病变,模拟恶性骨病。
要点
- 透析相关淀粉样变可表现为骨显像上非MDP高摄取的溶骨性病变,易误诊为转移瘤。
- 骨SPECT/CT中溶骨性病变无异常摄取而仅骨折处摄取,应警惕淀粉样变可能。
- 对长期透析患者出现非典型骨骼病变时,需认识此闪烁显像陷阱。
核心结论
- 透析相关淀粉样变可表现为骨显像上非MDP高摄取的溶骨性病变,可能模拟恶性骨病。
研究设计与样本
- 单例病例报告:70岁长期透析女性,因股骨颈病理性骨折及邻近溶骨性病变行骨SPECT/CT及组织病理学检查。
主要发现
- 骨SPECT/CT显示摄取仅位于骨折部位,溶骨性病变呈背景活性。
- 组织病理学经刚果红染色确诊淀粉样变。
临床怎么用
- 评估长期透析患者非典型骨骼病变时,应认识透析相关淀粉样变可表现为非MDP高摄取溶骨性病变这一闪烁显像陷阱。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dialysis-related amyloidosis (DRA) is a recognized complication of long-term dialysis caused by progressive deposition of β2-microglobulin amyloid in osteoarticular and periarticular tissues. Although its musculoskeletal manifestations are well described, bone lesions from DRA may be misidentified as malignant disease on imaging, posing a diagnostic challenge. CASE PRESENTATION: We describe a 70-year-old woman on long-term dialysis who presented with a pathologic femoral neck fracture and adjacent osteolytic lesions initially suspicious for metastatic disease or brown tumor. Bone SPECT/CT showed uptake only at the fracture site with background activity in the lytic lesions. Histopathological examination confirmed the diagnosis of amyloidosis by Congo red staining. CONCLUSIONS: This case illustrates that DRA may present as non-MDP-avid osteolytic lesions on bone scintigraphy, potentially mimicking malignant bone disease. Awareness of this scintigraphic pitfall is essential when evaluating dialysis patients with atypical skeletal lesions.
引用
- Chuang TL, Tseng CE, Lin PH, et al. Dialysis-related amyloidosis mimicking metastatic bone disease: a scintigraphic pitfall of non-MDP-avid osteolytic lesions on bone SPECT/CT. EJNMMI Res. 2026. PMID: 42204083. doi:10.1186/s13550-026-01453-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。